NAD: Firm's Laser Cap Hair-Regrowth Claims Not Supported, Despite FDA Clearance
This article was originally published in The Rose Sheet
Executive Summary
The Capillus82 Hair Regrowth Laser Cap may be "substantially equivalent" to the manufacturer's Capillus272 Pro device, based on FDA's 510(k) clearance, but NAD says hair-growth clinical findings from that "predicate" device cannot serve to substantiate claims for the untested Capillus82. The case illustrates complexities in the medical device segment, which increasingly is of interest to cosmetics companies.
You may also be interested in...
VGH Solutions Feels Pain In US Review For Basing OTC Device Ad Claims On Canada’s Approval
NAD advises VGH Solutions to pull pain relief claims and statements that am OTC device with FDA 510(k) clearance treats conditions including neuropathy. The firm offered studies and a Health Canada statement listing indications for the device to support claims not part of the US approved indication.
ASA Takes Shears To Hairburst Ad Claims; Volume & Growth Elixir Will Need Name Change
Hairburst’s hair-growth and hair-loss prevention claims on cosmetic products are inadequately substantiated, and many of the health claims it uses to promote food supplements are unauthorized, the Advertising Standards Authority says in a 14 Aug. decision.
J&J Recalls Neutrogena Light Therapy Acne Mask On Reports Of Eye Injuries
According to the J&J brand, a small subset of users with underlying eye conditions are potentially at risk of being injured by the FDA-cleared device, which uses red and blue LEDs to combat bacteria and inflammation associated with acne.